Insider · CIK 0001840738

Doyle John Brendan

Reports to the SEC for 2 companies · PURCHASE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001840738

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-01	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−8,567 sh	$1.28	−$11K	618,942
2026-04-16	CGTXCOGNITION THERAPEUTICS INCP Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.13	+$11.3K	627,509
2026-02-15	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−1,560 sh	$1.12	−$1,747.2	617,509
2026-02-04	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−26.9K sh	$1.03	−$27.7K	619,069
2026-02-03	CGTXCOGNITION THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+200K sh	—	—	645,990
2025-12-18	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−9,360 sh	$1.50	−$14K	445,990
2025-12-18	CGTXCOGNITION THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+30K sh	—	—	455,350
2025-07-29	CGTXCOGNITION THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+30K sh	—	—	434,710
2025-07-29	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−9,360 sh	$0.67	−$6,273.072	425,350
2025-05-01	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−9,692 sh	$0.45	−$4,334.262	404,710
2025-02-15	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−1,723 sh	$0.59	−$1,016.742	414,402
2025-02-04	CGTXCOGNITION THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+295K sh	—	—	416,125
2024-05-01	CGTXCOGNITION THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−8,699 sh	$1.95	−$17K	121,125
2024-02-15	CGTXCOGNITION THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+20K sh	—	—	129,824
2024-02-15	CGTXCOGNITION THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2023-05-01	CGTXCOGNITION THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+110K sh	—	—	109,824
2023-05-01	CGTXCOGNITION THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+110K sh	—	—	109,824
2021-08-05	CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−175K sh	—	—	0
2021-01-19	CHIASMA, INCStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000

Recent filings

Accepted (ET)
May 44
Doyle John Brendan0001104659-26-054858
SEC(opens sec.gov)
Apr 204
Doyle John Brendan0001104659-26-045511
SEC(opens sec.gov)
Feb 184
Doyle John Brendan0001104659-26-017068
SEC(opens sec.gov)
Feb 54
Doyle John Brendan0001104659-26-011074
SEC(opens sec.gov)
Dec 224
Doyle John Brendan0001104659-25-123721
SEC(opens sec.gov)
Jul 314
Doyle John Brendan0001062993-25-013357
SEC(opens sec.gov)
May 24
Doyle John Brendan0001062993-25-008394
SEC(opens sec.gov)
Feb 184
Doyle John Brendan0001062993-25-002703
SEC(opens sec.gov)
Feb 44
Doyle John Brendan0001062993-25-001620
SEC(opens sec.gov)
May 34
Doyle John Brendan0001062993-24-009329
SEC(opens sec.gov)
Feb 204
Doyle John Brendan0001062993-24-003651
SEC(opens sec.gov)
May 34
Doyle John Brendan0001062993-23-010091
SEC(opens sec.gov)
Aug 54
Doyle John Brendan0001209191-21-050010
SEC(opens sec.gov)
Jan 204
Doyle John Brendan0001209191-21-004402
SEC(opens sec.gov)

Companies

Address

C/O COGNITION THERAPEUTICS INC 2500 WESTCHESTER AVE.

PURCHASE, NY, 10577